Transcriptome analyses extend understanding of Streptococcus pyogenes regulatory mechanisms and behavior toward immunomodulatory substances

International Journal of Medical Microbiology

Volumn 297, Issue 7-8, 2007, Pages 513-523

  Riani, Catur ^a   Standar, Kerstin ^a   Srimuang, Somboon ^a   Lembke, Cordula ^a   Kreikemeyer, Bernd ^a   Podbielski, Andreas ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Cia regulator; Luivac immunostimulator; Streptococcus pyogenes; Transcriptomics; Virulence

Indexed keywords

GENE PRODUCT; IMMUNOMODULATING AGENT; LUIVAC; MATRIX PROTEIN; PROTEIN CIARH; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; CELL ADHESION; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EUKARYOTIC CELL; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; MUTANT; NONHUMAN; PROTEIN BINDING; REGULATORY MECHANISM; SEROTYPE; STREPTOCOCCUS PYOGENES; TRANSCRIPTOMICS; WILD TYPE;

EID: 35348864529     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.04.005     Document Type: Article

References (34)

1. Baldassarri L., Creti R., Recchia S., Imperi M., Facinelli B., Giovanetti E., Pataracchia M., Alfarone G., and Orefici G. Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J. Clin. Microbiol. 44 (2006) 2721-2727
2. Beres S.B., Richter E.W., Nagiec M.J., Sumby P., Porcella S.F., DeLeo F.R., and Musser J.M. Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc. Natl. Acad. Sci. USA 103 (2006) 7059-7064
3. Beyer-Sehlmeyer G., Kreikemeyer B., Hörster A., and Podbielski A. Analysis of the growth phase-associated transcriptome of Streptococcus pyogenes. Int. J. Med. Microbiol. 295 (2005) 161-177
4. Carapetis J.R., Steer A.C., Mulholland E.K., and Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5 (2005) 685-694
5. Cho K.H., and Caparon M.G. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol. Microbiol. 57 (2005) 1545-1556
6. Dagkessamanskaja A., Moscoso M., Henard V., Guiral S., Overweg K., Reuter M., Martin B., Wells J., and Claverys J.P. Interconnection of competence, stress and CiaR regulons in Streptococcus pneumoniae: competence triggers stationary phase autolysis of ciaR mutant cells. Mol. Microbiol. 51 (2004) 1071-1086
7. Echenique J.R., and Trombe M.C. Competence modulation by the NADH oxidase of Streptococcus pneumoniae involves signal transduction. J. Bacteriol. 183 (2001) 768-772
8. Echenique J.R., Chapuy-Regaud S., and Trombe M.C. Competence regulation by oxygen in Streptococcus pneumoniae: involvement of ciaRH and comCDE. Mol. Microbiol. 36 (2000) 688-696
9. Giammarinaro P., Sicard M., and Gasc A.M. Genetic and physiological studies of the CiaH-CiaR two-component signal-transducing system involved in cefotaxime resistance and competence of Streptococcus pneumoniae. Microbiology 145 (1999) 1859-1869
10. Graham M.R., Smoot L.M., Migliaccio C.A.L., Virtaneva K., Sturdevant D.E., Porcella S.F., Federle M.J., Adams G.J., Scott J.R., and Musser J.M. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc. Natl. Acad. Sci. USA 99 (2002) 13855-13860
11. Guenzi E., Gasc A.M., Sicard M.A., and Hakenbeck R. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol. Microbiol. 12 (1994) 505-515
12. Ibrahim Y.M., Kerr A.R., McCluskey J., and Mitchell T.J. Control of virulence by the two-component system CiaR/H is mediated via HtrA, a major virulence factor of Streptococcus pneumoniae. J. Bacteriol. 186 (2004) 5258-5266
13. Jareoncharsri P., Bunnag C., Tunsuriyawong P., Assanasane P., Voraprayoon S., and Pinkaew B. An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac) in the treatment of recurrent respiratory tract infections in Thai patients. Asian Pac. J. Allergy Immunol. 21 (2003) 223-230
14. Kreikemeyer B., Oehmcke S., Nakata M., Hofrogge R., and Podbielski A. Streptococcus pyogenes fibronectin-binding protein F2: expression profile, binding characteristics and impact on eukaryotic cell interactions. J. Biol. Chem. 279 (2004) 15850-15859
15. Lembke C., Podbielski A., Hidalgo-Grass C., Jonas L., Hanski E., and Kreikemeyer B. Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl. Environ. Microbiol. 72 (2006) 2864-2875
16. Mascher T., Zähner D., Merai M., Balmelle N., de Saizieu A., and Hakenbeck R. The Streptococcus pneumoniae cia regulon: Cia target sites and transcription profile analysis. J. Bacteriol. 185 (2003) 60-70
17. Mascher T., Heintz M., Zähner D., Merai M., and Hakenbeck R. The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in beta-lactam resistance. J. Bacteriol. 188 (2006) 1959-1968
18. Musser J.M., and DeLeo F.R. Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. Am. J. Pathol. 167 (2006) 1461-1471
19. Nakata M., Podbielski A., and Kreikemeyer B. MsmR, a specific positive regulator of the Streptococcus pyogenes FCT pathogenicity region and cytolysin-mediated translocation system genes. Mol. Microbiol. 57 (2005) 786-803
20. Podbielski A., Weber-Heynemann J., and Cleary P.P. Immunoglobulin-binding FcrA and Enn proteins, and M proteins of group A streptococci evolved independently from a common ancestral protein. Med. Microbiol. Immunol. 183 (1994) 33-42
21. Podbielski A., Woischnik M., Leonard B.A.B., and Schmidt K.H. Characterization of nra, a global negative regulator gene in group A streptococci. Mol. Microbiol. 31 (1999) 1051-1064
22. Ruah S.B., Ruah C., van Aubel A., Abel S., and Elsasser U. Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infections. Adv. Ther. 18 (2001) 151-162
23. Ruedl C., Frühwirth M., Wick G., and Wolf H. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin. Diagn. Lab. Immunol. 1 (1994) 150-154
24. Sebert M.E., Palmer L.M., Rosenberg M., and Weiser J.N. Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect. Immun. 70 (2002) 4059-4067
25. Shelburne S.A., Granville C., Tokuyama M., Sitkiewicz I., Patel P., and Musser J.M. Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human saliva. Infect. Immun. 73 (2005) 4723-4731
26. Sitkiewicz I., and Musser J.M. Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group A Streptococcus. Infect. Immun. 74 (2006) 1339-1351
27. Smoot L.M., Smoot J.C., Graham M.R., Somerville G.A., Sturdevant D.E., Migliaccio C.A.L., Sylva G.L., and Musser J.M. Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc. Natl. Acad. Sci. USA 98 (2001) 10416-10421
28. Spisek R., Brazova J., Rozkova D., Zapletova K., Sediva A., and Bartunkova J. Maturation of dendritic cells by bacterial immunomodulators. Vaccine 22 (2004) 2761-2768
29. Steurer-Stey C., Bachmann L.M., Steurer J., and Tramer M.R. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest 126 (2004) 1645-1655
30. Throup J.P., Koretke K.K., Bryant A.P., Ingraham K.A., Chalker A.F., Ge Y., Marra A., Wallis N.G., Brown J.R., Holmes D.J., Rosenberg M., and Burnham M.K. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol. Microbiol. 35 (2000) 566-576
31. Upton M., Tagg J.R., Wescombe P., and Jenkinson H.F. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 antibiotic peptides. J. Bacteriol. 183 (2001) 3931-3938
32. Voyich J.M., Sturdevant D.E., Braughton K.R., Kobayashi S.D., Lei B., Virtaneva K., Dorward D.W., Musser J.M., and DeLeo F.R. Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 100 (2003) 1996-2001
33. Zähner D., Grebe T., Guenzi E., Krauß J., van der Linden M., Terhune K., Stock J.B., and Hakenbeck R. Resistance determinants for beta-lactam antibiotics in laboratory mutants of Streptococcus pneumoniae that are involved in genetic competence. Microb. Drug Res. 2 (1996) 187-191
34. Zähner D., Kaminski K., van der Linden M., Mascher T., Merai M., and Hakenbeck R. The ciaR/ciaH regulatory network of Streptococcus pneumoniae. J. Mol. Microbiol. Biotechnol. 4 (2002) 211-216